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DAVID M. HUME, Moderator 
Dr. David M . Hume (Stuart Mc-
Guire Professor, and chairman, de-
partment of surgery, Medical College 
of Virginia, Richmond): I'd like to be-
gin by asking Dr. Doolan a question. 
Do you have any special technique or 
criterion, Dr. Doolan, for determining 
the reversibility of disease in a pa-
tient that is being dialyzed for acute 
renal shutdown? That is to say, how 
do you decide whether to turn the 
dialysis off after several days? 
Dr. Paul D. Doolan (director, clini-
cal investigation department, N aval 
Medical Research Institute, Bethesda, 
Maryland): I don't know if I under-
stand this question . 
Dr. Hume: Well , suppose you've got 
a patient with acute shutdown and you 
have dialyzed him, because you had to 
keep him going. How do you decide 
whether this patient is going to "open 
up" sometime on his own; how long 
do you keep dialyzing him if you don't 
have a chronic program, and when do 
you decide that the shutdown is ir-
reversible? 
Dr. Doolan: If he's got acute renal 
fa ilure, I don't know whether you can 
ever say it's irreversible. This question 
seems to emerge when you have shut-
downs of unknown origin, and you 
are wondering about whether the per-
son doesn't have acute glomerulone-
phritis, for example. If they don't open 
up in less than 30 days, then the likeli-
hood of their opening up is very re-
mote. 
Dr. Hume: How do you decide they 
have got acute glomerulonephritis? 
Dr. Doolan: Well, I think history 
and clinical appraisal is all I know of. 
If an adult is shutdown with acute 
glomerulonephritis, the prognosis is 
poor. I think it varies among different 
people as to when you feel justified in 
doing renal biopsy to see whether or 
not this will help you with making the 
decision of whether to continue dialy-
sis. I would say that, in my own ex-
perience, renal biopsies have not 
helped. 
Dr. Hume: Anybody else on the 
panel want to comment on this ques-
tion? 
Dr. John E. Kiley (professor of 
medicine, Albany Medical College, 
Albany, New York): I think when you 
see a patient with acute renal failure 
that does not open up after two or 
three weeks, you begin to see a some-
what characteristic behavior on the 
part of the physician handling the case. 
What we tend to do, first , is to support 
the patient by dialytic means, hoping 
that diuresis will ensue. But once you 
go into the second or third week, one 
certainly begins to feel pushed. After 
having eliminated any obstructive 
uropathy (by cystoscopic examination, 
etc.), we then do a renal biopsy. And, 
although there are some contraindica-
tions to doing a biopsy, it has been 
helpful in revealing a disease condi-
tion that we had not suspected, e.g., 
glomerulonephritis, overwhelming pye-
lonephritis, and infarction of the kid-
ney. These conditions tend to make 
one turn off the dialyzer, because this 
is not acute tubular necrosis, and the 
kidney will not regenerate. The other 
thing to do would be to put a catheter 
up by way of the femoral artery to the 
level of the renal artery and inject a 
radioopaque dye. In this way, one can 
study the vascularity of the kidney. In 
some instances we have discovered 
that there has been bilateral infarction 
which we didn't suspect. This usually 
occurs when the patient has infarcted 
one kidney, say a year or two earlier, 
without its being clearly diagnosed, 
and later the patient has infarcted the 
other kidney. So, renal biopsy and 
pyelography can be helpful, when, af-
ter a month of dialysis you're beginning 
to wonder whether you are not rapidly 
going into chronic dialysis, inadvert-
ently. Perhaps someone else on the 
panel has had more experience than 
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I with the use of the newer diagnostic 
techniques of infusion pyelography. 
Dr. Hume: Some patients don't 
"open up" for 60 days. The question 
is, at the end of 30 days, what do you 
do? 
Dr. Belding H . Scribner (chief, di-
vision of kidney disease, department 
of medicine, University of Washington, 
Seattle): We're obviously confronted 
with this problem continually, because 
we do have a chronic program that is 
full. But at the same time, we are in 
a very serious dilemma in this kind 
of situation. I underscore completely 
what John Kiley says about the use 
of the biopsy at the 30-day point, so 
to speak. The other side of the coin 
here is, if you do find normal glomeruli 
and tubular necrosis at 30 days, then 
you are committed to keep the patient 
going on dialysis indefinitely. I know 
of one patient from Stanley Sheldon's 
group in England that went 90 days 
with tubular necrosis and then opened 
up. So, on the hopeful side, if you do 
come up with this diagnosis on renal 
biopsy, even in the presence of anuria, 
then you are obliged to go on. If you 
are worried about the vasculature, I 
think the aortogram may be done in 
60 days or 90 days, if you are still 
"sitting" on the case. I can not eluci-
date the question Dr. Kiley raised 
about the newer radiographic tech-
niques. 
Dr. Joseph H . Magee (director of 
renal section, department of medicine, 
Medical College of Virginia)1 • I want 
to allude to what Dr. Scribner just 
said. One of the abstracting journals 
had reported two cases of cortical in-
farction, where dialysis was carried 
out for 70 to 80 days before recovery. 
The authors believed that some one-
sixth or one-fifth of nephrons, which 
are juxtamedullary, will come back 
and function if you dialyze them long 
enough. So I wonder if you aren't on 
the griddle for about two to three 
months, where shock or cortical in-
farction might have been the cause of 
shutdown. 
1 At present, assistant professor of 
medicine, Jefferson Medical College, 
Philadelphia. 
Dr. Hume: Would anybody on the 
panel like to tell about his experience 
with the use of large quantities of 
contrast material, or would anybody 
like to comment on the use of radio-
active materials, renal scans or radio-
renograms, as assists in determining 
whether renal artery thrombosis bas 
occurred-Dr. Kiley? 
Dr. Kiley: Well, of course, I can't 
see how the use of radioactive sub-
stances is going to help you, because 
they don't really reflect the blood flow, 
but rather the ability of the tubular 
cells to concentrate and excrete the 
isotope. These patients may have 
neither blood flow nor secreting cells, 
so I would not be enthusiastic about 
these procedures. 
Dr. Hume: If you have neither 
blood flow nor kidney cells, you 
wouldn't get any uptake, but if you 
have got some uptake, then that would 
be some evidence of vascularity. 
Dr. Kiley: If you're looking for 
vascularity, I still think that renal 
angiography would be beter than iso-
topes. 
Dr. Hume: Dr. Kiley, in your earlier 
discussion (paper on artificial dialysis 
in adults), you talked about using dial-
ysis for hypercalcemia. I am wonder-
ing if you would advocate this form of 
therapy in hypercalcemic crisis, rather 
than operating on a patient who has 
hyperparathyroidism and hypercal-
cemic crisis, and removing his para-
thyroid adenoma. Another condition 
I noticed on your list was ammonia in-
toxication, and I wonder how your 
results have been with this. 
Dr. Kiley: Well, first, I'll put my 
guard up by saying that at that time I 
was showing a list of situations which 
have been recorded as successfully 
treated by dialysis. Now, with hyper-
calcemia, we have an interesting situa-
tion there. I have not personally treated 
a hypercalcemic crisis by dialysis, so 
I am in no position to disagree with 
Dr. Glenn's2 statement that parathy-
roidectomy is preferable. However, as 
2 Dr. James F. Glenn, professor and 
chairman, department of urologic surgery, 
Duke University, had spoken earlier on 
surgery in the prevention of uremia. 
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a surgeon, I would like to strike back 
by asking you if this would not be an 
extremely difficult type of emergency 
operation. The hypercalcemia may be 
due to hyperactivity of the parathyroid, 
which is deeply situated within the 
body. I think the complexity and diffi-
culty of this surgery is at least a factor 
suggesting that dialytic therapy might 
be more efficacious; it is certainly more 
straightforward. How do you feel 
about this operation itself? 
Dr. Hume: We have not had much 
experience with this. We had one pa-
tient who we thought had this problem. 
He certainly had a hypercalcemic 
crisis, and we dialyzed him for a 
short while, with some fall in calcium, 
although its level did not fall strikingly. 
We then took the patient to the oper-
ating room, explored the neck and then 
made the diagnosis of widespread 
metastatic disease, which hadn't shown 
up in x-rays. The patient ultimately 
died of malignant disease. Dr. Magee, 
do you recall that patient? I've for-
gotten exactly what the results of dial-
ysis were. 
Dr. Magee: I think we got calcium 
down from about 20 to 18. We just 
dialyzed for minimum number of 
hours and weren't getting anywhere 
and proceded with the operation. 
Thomas and co-workers3 in a review of 
about 14 such cases, said they believed 
the thing to do was to get them right 
up to the operating table, because you 
just can't dialyze fast enough. 
Dr. Kiley: Well, I would disagree 
with that. I think that if you are equat-
ing a good operation with relatively 
poor therapy, that certainly is true, 
but I also think that there are better 
medical ways of managing this dis-
order than by dialysis. As a matter of 
fact, I think dialysis may be weak, 
because you are dealing with a double 
equilibrium caused by abnormal para-
thyroid hormone, so you will have 
calcium coming out of the skeleton 
just about as rapidly as you can dialyze 
it out. On the other hand, by the use 
3 Thomas, W. C., Jr., J . G . Wiswell, 
T. B. Connor, and J.E. Howard. Hyper-
calcemic crisis due to hyperparathyroid-
ism. Am. J. Med. 24: 229-239, 1958. 
of sulphate and citrate, and, at least 
theoretically, EDTA, you can cut down 
considerably on the amount of ionized 
calcium that is present. This kind of 
medical therapy, although a temporary 
measure, can give you a good deal of 
time, even in the middle of the night, 
to prepare the patient and the operat-
ing room for surgery. And it can fore-
stall the disaster that sometimes occurs 
with sudden death. So, I wouldn't mini-
mize the usefulness of the right kind of 
medical therapy. 
Dr. Doolan: I don't know whether it 
was a tribute to Dr. Kyle, my old boss, 
but I never saw a hypercalcemic crisis 
with hyperparathyroidism, and he had 
only a few cases. I have seen hypercal-
cemic crises with metastatic bone dis-
ease. This is the case in which you are 
not worried about operating. You can 
lower calcium by giving these people 
steroids, or you can lower it by doing 
peritoneal lavage, and, if you want 
to, you can put EDTA in the perito-
neal lavage solution and remove even 
more calcium that way. 
Dr. Hume: That's a good thought. 
Actually, there have been about 40 of 
these reported in the literature and 
the mortality is about 50%. 
Dr. Doolan: With the hyperparathy-
roid? 
Dr. Doolan: Yes. 
Dr. Magee: And there are a lot more 
now. 
Dr. Doolan: Well, my only point 
was, they're not all surgical. 
Dr. Hume: No, not right away. We 
get them in the end, though, because 
there is no medical cure for hyperpara-
thyroidism. 
Dr. Doolan: The discussion has 
spun around how fast the patient with 
hypercalcemia should get to the op-
erating room. But, what about the 
hypercalcemia that is not due to hyper-
parathyroid? 
Dr. Hume: Well, we don't take those 
to the operating room. 
Dr. Doolan: This is why I mentioned 
peritoneal lavage, steroids, and EDT A 
in the peritoneal lavage solution. 
Dr. Hume: It is true that the ma-
jority of the hypercalcemic crises that 
we have seen here have been due to 
carcinoma of the breast, and we usu-
ally treat those with steroids to get 
them off the hook. Now, Dr. Kiley, I 
would like to ask you about dialysis 
in ammonia intoxication. 
Dr. Kiley: We demonstrated quite a 
few years ago that the ammonia ion 
is very efficiently removed by a dia-
lyzer, and we have used this with some 
gratifying results in about half a dozen 
patients. The thing I want to empha-
size is that I don't believe at all that 
this is effective clinical use of dialysis. 
Ammonia toxication is almost invaria-
bly handled better by other approaches. 
Dr. Hume: Were these people in 
hepatic coma, or were they people who 
had ingested some household deter-
gent? 
Dr. Kiley: The patients who were 
successfully treated were patients with 
portal cirrhosis who were getting along 
quite well, who then had a massive 
gastrointestinal hemorrhage. The hem-
orrhage was then stopped one way 
or another, but they went into am-
monia intoxication from digestion of 
the blood in the gastrointestinal tract, 
and they were benefited by the removal 
of this excess ammonia. But I think 
this has very little practical general 
clinical worth. 
Dr. Hume: Dr. Kiley, when I was 
an intern and resident, we used to see 
patients with various types of renal 
shutdown and potassium intoxication. 
In those days, a major indication for 
dialyzing a patient was potassium in-
toxication. We used to go scurrying 
around trying to get the patient just 
on the razor's edge, watching for EKG 
changes of potassium intoxication. And 
we were in sort of a sweat to see 
whether he was going to survive, and 
to judge the right moment to put him 
on the kidney. Now you suggest in 
your talk that we ought to get an EEG 
instead of an EKG, to decide when to 
put the patient on the kidney. This is 
harder to get than an EKG, and it is 
somewhat more difficult to interpret. 
Do you really feel that this is the way 
to decide when to put a patient on the 
kidney? 
Dr. Kiley: Well, first of all, let us be 
clear that the EEG has nothing to do 
with potassium intoxication. Although 
I was possibly skipping along to catch 
up a little time, I did preface my slide 
of the EEG with the statement that 
it was not generally available. And I 
would agree with your comment that, 
were this to be efficiently used, it must 
become more available clinically, and 
I think we must work more to that end. 
We have it fairly available now be-
cause this is a particular interest of 
ours. We have a portable EEG ma-
chine which can be taken to the ward, 
and you can count the frequency of 
the waves per second as they come off 
the machine. So, the EEG can become 
clinically useful, and I think it is 
something we must progress with. 
Really, what we are striving for here 
is a relatively simple electronic counter 
which will sort the seconds into two 
stacks; those in which the wave fre-
quency of the EEG is above six and 
those in which the wave frequency is 
below six. The latter is a clearly ab-
normal situation. I do think that all 
of us are now using the EKG for po-
tassium intoxication, particularly since 
the cardioscope has become generally 
available. If we have a potassium prob-
lem, we move the cardioscope into 
the room and turn it on and monitor 
the EKG continuously. 
Dr. Hume: I was wondering, since 
Dr. Scribner has demonstrated that 
dialysis is so easy to do in the base-
ment, why don't you simply dialyze the 
patients repeatedly when they have 
uremia, rather than rely on some par-
ticular danger signal to put them on 
dialysis? 
Dr. Kiley: I think you're quite right, 
and I think that this is where we should 
be going. And, we should be using 
the artificial kidney and other dialyzers 
more as the human kidney, to preserve 
normalcy, rather than to correct a very 
abnormal situation. But I think that, in 
the present state of our knowledge, the 
main question is just how much dialy-
sis is ideal. We just don't know that, 
because we have not yet correlated the 
changes in metabolism, particularly 
nitrogen metabolism, with these phys-
iological changes. The thing I like 
about the EEG is that for the first time, 
we have something reasonably objec-
tive in altered physiology which we can 
use in clinical uremia. I was all sort of 
up-in-the-air in clinical uremia because 
we usually stood at the foot of the 
bed and looked at the patient, and 
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wondered how sick he was, and that is 
hard to go on. 
Dr. Hume: Dr. Finberg, I wonder if 
in the course of dialysis for poisons of 
one sort or another you ever see a re-
bound phenomenon after the dialysis 
is done. That is, the patient wakes up 
from dialysis and then, sometime later, 
he lapses back into coma. Has this 
ever been a problem? 
Dr. Laurence Finberg (chief, di-
vision of pediatrics, Montefiore Hos-
pital, and professor of pediatrics, Al-
bert Einstein College of Medicine, New 
York): In most of the common poison-
ings that we see that is not a problem. 
There are some poisonings in which 
that has been notoriously reported to 
be the case. Then, you have to go back 
and dialyze again. 
Dr. Hume: Dr. Finberg, supposing 
you have a problem, as occasionally 
comes up, that a child is born without 
kidney function. Is there any effective 
way to dialyze the newborn baby, or 
otherwise to manage the problem? 
Dr. Finberg: Yes, I think there are 
two comments pertinent to this ques-
tion. One is that the infant is probably 
the only living organism that can sur-
vive without any renal function at all, 
and without any artificial aid, for long 
periods of time. The record is up to six 
weeks. This is because the infant is so 
rapidly growing that if the absence of 
urine formation is not a consequence 
of some kind of disease which in itself 
induces katabolism, he will grow, and 
will so expand his body fluid compart-
ments that they can actually hold the 
toxic substances in them in so dilute 
a form as to permit growth. This will 
be true if the infant is on the proper 
feed , and the ideal feed for this is 
human-breast milk. And that is how 
the record was set. The mother took 
her baby home, who subsequently 
turned out to have no renal mass at 
all. She didn't bring him to the hos-
pital, not thinking it was terribly im-
portant that he hadn't put out any 
urine, until he was almost six weeks 
old. As for dialysis in infants, you can 
dialyze small infants if they have an 
abdominal cavity that is approachable. 
You can do it with peritoneal dialysis, 
of course, and this is what we talked 
about before. I am told the McNeal-
Collins kidney can be adapted for 
small infants, but I haven't actually 
seen it in action myself. The other, 
larger devices are almost impossible to 
use on a small infant, even with trying 
to cut down the coil area and ex-
teriorized blood volume. 
Dr. Hume: Has anybody on the 
panel dialyzed a child under two years 
of age? 
Dr. Scribner: Dr. Robert Hickman, 
in the department of pediatrics in Seat-
tle, has been working on the problem. 
It seems to me the number-one require-
ment for infant dialysis is a small 
stable external circuit. I think Dr. 
Hickman has dialyzed a child only 
four weeks old, and he is using the Kiil 
half-length, one-layer unit, with a com-
pletely rigid external circuit, and no 
blood pumps. It is about a quarter the 
size of the unit we use for adults. If 
you fully prime the external circuit, 
the infant's vasculature cannot tell 
when he is on or off the dialyzer. The 
big problem in dialysis is to shift the 
blood from the equipment to the small 
child and back again. With a small 
rigid external circuit, we've had good 
luck in infant dialysis. 
Dr. Hume: Do you put the child 
on a set of scales to be sure how much 
weight he is gaining or losing? 
Dr. Scribner: It isn't necessary un-
less you're filtering large amounts of 
salt solution and then, of course, it's 
very helpful to have him on a scale. As 
far as the blood shift is concerned, if 
you have a rigid external circuit that is 
small and fully primed, there's no 
problem with bloodshift. 
Dr. Hume: Dr. Magee, I wonder if 
you want to comment on some of the 
things Dr. Scribner has mentioned 
briefly, that is, the medical manage-
ment of a patient with chronic uremia 
who is not yet ready for dialysis? 
Dr. Magee: Picking out some of the 
things the speakers have brought up 
today, the common situation now is 
that practically no uremic patient 
comes in on the ward about whom 
you are not asked whether there is 
some reversible feature. Twenty-five 
years ago there were no nephrologists 
because there was nothing for them to 
do. Most people didn't believe for 100 
years after Bright's description of 
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uremia that there was any such thing 
as reversible uremia. The things that 
seem to have come along to have 
changed all this were: 1) Weiss and 
Parker• showed that pyelonephritis was 
a common cause of chronic uremia. 
They picked out, retrospectively, a lot 
of reversible cases that came in with 
a pericardia! friction rub or uremic 
frost, and then left the hospital. Some 
of the older physicians didn't think 
they'd ever seen this but here there were 
some cases. 2) The salt-losing nephritis 
emphasized by Thorne and colleagues'; 
when the patients went into shock, 
instead of giving them adrenocortical 
hormones you only had to give salt. 
3) Then along came the exponential 
growth of blood banks and non-expo-
nential growth of technicians and we 
had a large number of transfusion re-
actions. A lot of younger fellows really 
got going from the encouraging ex-
perience of bringing some of these 
patients through. These easy ones are 
not seen any more, but they just rein-
forced the concept of reversible ure-
mia. 4) W. J. Kolff's book, New Ways 
of Treating Uremia ,6 which had the 
artificial kidney in it, but most im-
portantly, it had the high-caloric, low-
protein feedings and the protein-spar-
ing feeding, and the necessity of 
restricting water, to avoid pulmonary 
edema. 5) And then came the electro-
cardiogram and the flame photometer, 
which helped tell us when the potas-
sium is elevated. 
Dr. Hume: I would like to make a 
couple of comments relative to Dr. 
Scribner's talk comparing chronic di-
alysis and transplantation, and then 
ask him to comment on my remarks. 
In the first place, I think we all ought 
to admit right off the bat that some 
form of chronic dialysis is essential 
' Weiss, S., and F. Parker, Jr. Pyelo-
nephritis: its relation to vascular lesions 
and to arterial hypertension. Medicine 18: 
221-315, 1939. 
5 Thorn, G. W., G. F. Koepf, and M. 
Clinton, Jr. Renal failure simulating 
adrenocortical insufficiency. New Engl. 
l . Med. 231 : 76-85, 1944. 
6 Kolff, W. J. New Ways of Treating 
Uremia . London: J. and A. Churchill, 
Ltd. 
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to any transplant program. That is, 
without Dr. Scribner's help, and with-
out the use of his device, our own 
program might never have gotten off 
the ground. Secondly, transplantation 
is not a therapeutic program at the 
present time; it is an investigative pro-
gram. It's difficult to talk to Dr. Scrib-
ner without being challenged by him, 
because he regards chronic dialysis as 
a therapeutic program. This immedi-
ately puts you on the defensive. So, 
I'd like to point out the insufficiencies 
of chronic dialysis, and correct a few 
figures that have been given about 
transplantation. 1) The patients who 
were cared for by him for chronic 
dialysis were a highly select group of 
intelligent people. It is not everybody 
who can go down in his basement and 
dialyze himself. At least % of the pa-
tients we have done transplants on, 
not only couldn't dialyze themselves, 
they barely had the intelligence to void! 
Our overall objective has not been to 
see what percentage of survival we 
can get, but what we can learn about 
transplantation. 2) Chronic dial ysis is 
pretty much out with respect to chil-
dren because it does interfere with 
growth and sexual maturity, as Dr. 
Scribner has said. 3) The number of 
patients who can be benefited by 
chronic dialysis is very small. Suppose 
for a moment that you were to take 
the point of view that the present 
objective of either of these two meth-
ods is to keep the greatest number of 
people alive. (Although this is not the 
point of view that we take, it is the 
point of view that Dr. Scribner takes.) 
In his own setup in Seattle, Washing-
ton, he has had six patients on hemodi-
alysis in a five-year period; five of the 
six patients are still living. He's done 
six patients on peritoneal dialysis ; five 
of these patients are still Jiving. And 
he's got two patients in their base-
ments. That's a total of 12 patients in 
five years, who are living who would 
otherwise have died. Our own program 
of transplantation has been going only 
two years. We have 28 patients Jiving 
who would otherwise have died . None 
of Dr. Scribner's patients is cured ; they 
all still have their disease. None of his 
patients is really well, but this is not 
true of any of the transplant patients 
either. 4) Hypertension does occur in 
patients with chronic renal disease, 
even in those on · a low-salt diet. We 
have seen this in two instances out of 
the 50 patients we've had on chronic 
dialysis. Dr. Scribner hasn't seen it in 
his six patients, but it does occur, and 
it is a problem and one that you can-
not solve with dialysis but you can 
solve with transplantation. 5) The de-
grees of independence of the two type~ 
of patients, that is, the patient with 
kidney transplant and the patient on 
dialysis, are quite different. Even if 
dialysis is done in the basement, and 
even if you can dialyze yourself at 
night while you sleep, it does encroach 
upon your independence to a greater 
extent than does the normally function-
ing kidney transplant in a well patient. 
6) None of the patients on chronic di-
alysis really ever regain their pre-sick-
ness weight. They do regain some 
weight, but they never are as healthy 
as the patients with good transplants, 
although not all patients with trans-
plants have good ones. 7) Almost all of 
the patients on chronic dialysis re-
quire blood transfusions which are 
expensive and dangerous. 8) Neuropa-
thy is almost never corrected by 
chronic dialysis-hemodialysis, that is. 
9) The mortality figures are somewhat 
misleading. If you take Dr. Scribner's 
figures and show them on a slide today, 
71 % of the patients on chronic dialysis 
are now surviving. This figure is not 
too different from the figure for the 
larger series of transplant patients. 
Sixty-two per cent of all the patients 
we have done from the very first one 
are surviving. Of all transplants from 
related donors in the three largest 
groups in the country, 73 % are surviv-
ing. Of our own cadaver transplants, 
70% are surviving; and if we took only 
our last eight months' cases-93 % of 
those are surviving. Even if we took all 
the patients we did in the first year, 
all of whom are now one or two years 
post-transplant, 46 % are still living. 
Four of the first six patients we did are 
still living, and the two that died, died 
of total body radiation, which we no ' 
longer use. Virtually all of our patients 
have been on chronic dialysis before 
transplantation, ana au or mem preter 
the transplant to chronic dialysis. The 
figures which Dr. Scribner quoted, i.e., 
that 70% of identical twins who could 
have lived five years had died of the 
disease of the host, are figures that 
were reproduced in a recent editorial,' 
and are incorrect. The facts are 80% 
of all twins done in the last 10 years 
are living at present. Although it has 
been reported that occasionally either 
the twin kidney or a homografted 
kidney has developed the disease of the 
host, this has not happened as a rule, 
and it has not happened in any of our 
homotransplants or any of those in 
Denver. There's something more than 
100 cases in this combined series, so, 
I think it must be extremely rare. He 
quoted Dr. Don Thomas' thoughts, 
namely, that he figures that 5 to 20% 
of patients who were transplanted had 
a chance of living two years, and that 
less one percent of them had a chance 
of living for four years. Dr. Thomas 
has recently moved to Seattle and it 
is understandable that he would have 
these thoughts. Dr. Scribner is a very 
convincing fellow. Had Dr. Thomas 
thought otherwise he might be carried 
away in the middle of the night. The 
actual figures from the largest series 
in the country are that, of those pa-
tients who could have lived from one 
to two years, 40 to 45 % are living. 
Of our own patients who could have 
lived for two years, which is a very 
small group, 50% are still Jiving. Dr. 
Scribner also says that the dialysis pro-
gram works without doctors. But the 
patient with basement kidney must 
have about $1,500 a year in profes-
sional fees. Furthermore, in our own 
dialysis unit, which is modeled after 
Dr. Scribner's, Dr. Bower hasn't had 
a vacation in a year. Even though our 
program is run by nurses and tech-
nicians, Dr. Bower doesn't leave town 
for any length of time. I would like to 
conclude these remarks by saying there 
is really no competition between 
chronic dialysis and transplantation be-
cause the goals of the two are vastly 
different. But, I think if there is going 
7 Elkinton, T. Russell. Moral problems 
in the use of borrowed organs. artificial 
and transplanted. Annals int. Med. 60: 
309-313, 1964. 
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to be an ultimate solution to the prob-
lem, that the patient with a normally 
functioning kidney, urinating in a nor-
mal fashion, with a completely normal 
life, who feels perfectly well, and has 
regained his pre-sickness weight, is in 
a little better situation than the fellow 
with a home kidney in the basement. 
Dr. Scribner, would you like to com-
ment on this? 
Dr. Scribner: I guess we could stay 
around a couple of hours and really 
have at it, but time is over already. 
I'll just make one or two brief re-
marks. We only had 12 patients at the 
University of Washington because it 
was not our job to take all the patients 
that could come our way. Our job was 
to demonstrate the feasibility of the 
method, to get on with the job of do-
ing research to improve the method, 
and to learn all we could about the 
biochemistry of what's going on. Actu-
ally, unless we have had a new re-
search project, such as the home pro-
gram, we have not added a patient to 
our program in over two years. In con-
trast, of course, the new center down-
town now carries 13 patients and is 
about to go up to 30, so the statement 
that there are fewer patients being 
benefited by chronic dialysis is simply 
a function of economics. If we had the 
money, we could take everybody in 
King County and we think we are 
going to be able to do this soon with 
the combination of the center and the 
home program. One or two other 
points. To say that 80% of all twins 
done are now alive is not necessarily 
contradicting the statement that 70% 
of the twins who could have survived 
five years are now dead. 
Dr. Hume: This statement is incor-
rect. 
Dr. Scribner: This was the state-
ment that Don Thomas got from the 
group in Boston about two weeks ago. 
I do believe that chronic dialysis, based 
on our experience, is an accepted 
method of treatment. This is borne out 
by the world survey that we have just 
conducted. In this survey we asked, 
"can any well-trained internist, if he 
wants to, maintain a patient on chronic 
dialysis?", and all 20 investigators 
said yes. So, chronic dialysis is no 
longer an experimental technique; it is 
a therapeutic technique available to 
anyone who wants to get in, roll up 
his sleeves, and go to work. The prob-
lem is that we need time to activate 
the units, we need money, and proper 
facilities. And, incidentally, with all 
due respect to the excellent program 
here (at the Medical College of Vir-
ginia), they do not have proper facili-
ties for chronic dialysis on an out-
patient basis. The chronic dialysis 
program here is solely for the support 
of the excellent transplant research 
program that is going on. 
Dr. Doolan (to Dr. Hume): You 
mentioned something about someone 
overpowering someone. I would find it 
hard for anybody to overpower you, 
Dave. There really wasn't any argu-
ment the way you wound it up, in 
that nobody argues with the ultimate 
desirability of having an intact kidney 
in you. But, let me ask you, how many 
transplants with non-maternal donors 
have survived over a year? 
Dr. Hume: Of the patients that 
started off with a non-maternal kidney 
that could have survived more than a 
year, there were two, and they are 
both alive. Of the patients that have 
received cadaver kidneys, an unrelated 
group, 70% are still alive. 
Dr. Doolan: After one year? 
Dr. Hume: No, because they haven't 
all been a year. 
Dr. Doolan: Dave, will you make 
the statement here and now that you, 
a surgeon, can guarantee a more than 
one-year survival of 50 or 70% in un-
related homotransplants? 
Dr. Hume: Of course not, that 
would be a ridiculous statement to 
make. 
Dr. Doolan: Well, boy, you threw 
around an awful lot of statistics. I don't 
know whether you are talking about 
two weeks, two months, or what. 
Dr. Hume: Well, I think the most 
important figures in this regard are 
that if you take the patients who have 
been done more than a year ago, who 
are still living at the present time, so 
that all of these patients are from one 
to two years, and are patients who 
couldn't have lived more than a year, 
46% of them are living. 
Dr. Doolan: Would you give me that 
once more? I'm a little slow. 
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Dr. Hume: Yes. Take the patients 
done in the first year of our program. 
Our program began August, 1962. All 
those patients are now from one to two 
years from their transplant. Now take 
all the patients who could have lived 
during that time-there were 13 such 
cases who were done during that year 
-six of those patients are now living, 
which is 46% of the group. If you 
take those patients who have now been 
one year, which is not quite the first 
year, all told, 44% of patients who 
could have lived during that year are 
now living. 
Dr. Doolan: I would only say that, 
as far as I know, unrelated transplants 
is strictly an investigative technique 
and if you select your patients well, 
from what I know of the Seattle group, 
it's a therapeutic technique. So, the 
only position I'm left with here is 
wondering why you have the sensi-
tivity you do in the first place. 
Dr. Hume: I have no particular sen-
sitivity. I think that the figures do rep-
resent the facts as they are now. I think 
it's important to feel that transplanta-
tion results are good enough to justify 
any investigation on this program. And 
I think it's good that the results of 
hemodialysis are not so good that one 
should settle for this type of thera-
peutic regimen at the present time. 
That's all. 
Dr. Scribner: I don't wish to give up 
keeping score here, but could I take 
advantage of this situation to ask you 
to comment on what the fundamental 
improvements have been in the tech-
nique of transplantation in the past 
year or two. I have a feeling that 
things are improving. 
Dr. Hume: I think the thing we've 
perhaps observed better than before 
are, first of all, that at the first indica-
tion of rejection, immunosuppressive 
therapy is increased. Secondly, I think 
the use of local radiation has helped 
and I think this may be one of the 
reasons that our cadaver transplants 
are coming along better than some. 
This is something that has come out of 
the laboratory that seems to help clin-
ically. Thirdly, the use of prednisone 
has been extremely valuable in pre-
venting rejection. Fourthly, the prepa-
ration of patients for surgery by the 
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types of chronic dialysis now available 
is vastly better. We started off with 
peritoneal dialysis and now we use the 
Scribner technique. Fifthly, I think that 
keeping the patients on hand longer 
has given us the time to observe them 
and manage them better after trans-
plant. 
Dr. Doolan: May I make one more 
comment in a different vein, Dave, and 
that touches on statistics. I recom-
mended for the military section of the 
AMA that the treatment of post-trau-
matic renal insufficiency should be 
prophylactic hemodialysis a la Seattle 
group technique, which I think is the 
finest available. The way I justify this 
statistically is that Scribner and Bob 
Hagstrom are the only ones that have 
lowered mortality rate in acute renal 
insufficiency in the post-traumatic 
group. To the best of my knowledge, 
that's where the issue stands statis-
tically at the moment. 
Dr. Scribner: I'm terribly biased in 
this regard, but I feel that the prophy-
lactic approach to acute renal failure 
just makes eminent good sense as Paul 
just very well stated, and since dialysis 
in a properly-run center such as you 
have here in Richmond is virtually 
without risk, and uremia is dangerous 
to a person with fractures and so on, 
it just is the only way to do it. 
Dr. Hume: Thank you very much 
for your kind attendance. 
"The basic texture of research 
consists of dreams into which the 
threads of reasoning, measurement, 
and calculation are woven". 
Albert Szent-Gyorgyi, Introduc-
tion to a Submolecular Biology. 
New York and London: Academic 
Press, 1960, p 1. 
